186 related articles for article (PubMed ID: 10192206)
1. The simultaneous treatment of inflammatory bowel diseases and associated pyoderma gangrenosum with oral cyclosporin A.
Capella GL; Frigerio E; Fracchiolla C; Altomare G
Scand J Gastroenterol; 1999 Feb; 34(2):220-1. PubMed ID: 10192206
[No Abstract] [Full Text] [Related]
2. Pyoderma gangrenosum associated with Takayasu's arteritis responding to cyclosporin.
Fearfield LA; Ross JR; Farrell AM; Costello C; Bunker CB; Staughton RC
Br J Dermatol; 1999 Aug; 141(2):339-43. PubMed ID: 10468813
[TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis carinii pneumonia in a patient with pyoderma gangrenosum treated with cyclosporin.
De Silva BD; Buxton PK
Br J Dermatol; 2000 Sep; 143(3):683-4. PubMed ID: 10971375
[No Abstract] [Full Text] [Related]
5. [What is your diagnosis? Pyoderma gangrenosum].
Wieler B; Vorburger D; Lindenmann N
Praxis (Bern 1994); 2009 Dec; 98(25):1497-8. PubMed ID: 20013685
[No Abstract] [Full Text] [Related]
6. [Infliximab for the management of pyoderma gangrenosum in inflammatory bowel disease: one for all?].
Tanczos BT; Baumgart DC
Z Gastroenterol; 2006 Jul; 44(7):609-10. PubMed ID: 16823703
[No Abstract] [Full Text] [Related]
7. Bullous pyoderma gangrenosum secondary to underlying multiple myeloma: treated with ciclosporin.
Razmi T M; Muhammed H; Handa S; Malhotra P; Sharma S; Saikia UN; Aggarwal R; Dogra S
Clin Exp Dermatol; 2019 Mar; 44(2):e13-e15. PubMed ID: 30294832
[No Abstract] [Full Text] [Related]
8. Pyoderma gangrenosum successfully treated with cyclosporin A.
V'lckova-Laskoska MT; Laskoski DS; Caca-Biljanovska NG; Darkoska JS
Adv Exp Med Biol; 1999; 455():541-5. PubMed ID: 10599396
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine.
Futami H; Kodaira M; Furuta T; Hanai H; Kaneko E
J Gastroenterol; 1998 Jun; 33(3):408-11. PubMed ID: 9658322
[TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum associated with hidradenitis suppurativa.
Ah-Weng A; Langtry JA; Velangi S; Evans CD; Douglas WS
Clin Exp Dermatol; 2005 Nov; 30(6):669-71. PubMed ID: 16197385
[TBL] [Abstract][Full Text] [Related]
11. Sarcoidosis and pyoderma gangrenosum: an exceptional association. The role of trauma and immunosuppressive agents.
Herrero JE; Mascaró JM; Llambrich A; Herrero C
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):97-9. PubMed ID: 15649201
[TBL] [Abstract][Full Text] [Related]
12. Two cases of bullous pyoderma gangrenosum complicated by Epstein-Barr virus infection.
Zhou Y; Chen W; Zhang X; Huang F; Wang D
Eur J Dermatol; 2018 Jun; 28(3):370-371. PubMed ID: 29952293
[No Abstract] [Full Text] [Related]
13. [Therapy-resistant pyoderma gangrenosum--treatment with mycophenolate mofetil and cyclosporine A].
Michel S; Hohenleutner U; Mohr V; Landthaler M
Hautarzt; 1999 Jun; 50(6):428-31. PubMed ID: 10427512
[TBL] [Abstract][Full Text] [Related]
14. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease.
Friedman S; Marion JF; Scherl E; Rubin PH; Present DH
Inflamm Bowel Dis; 2001 Feb; 7(1):1-7. PubMed ID: 11233655
[TBL] [Abstract][Full Text] [Related]
15. Peripheral regional aseptic neutrophilic lymphadenopathy associated with pyoderma gangrenosum.
Al-Niaimi F; Cox NH
Br J Dermatol; 2009 Nov; 161(5):1206-7. PubMed ID: 19678821
[No Abstract] [Full Text] [Related]
16. Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin.
Sinagra E; Orlando A; Renna S; Maida M; Cottone M
Inflamm Bowel Dis; 2012 Aug; 18(8):E1594-5. PubMed ID: 22038892
[No Abstract] [Full Text] [Related]
17. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
18. Tofacitinib for the treatment of refractory pyoderma gangrenosum.
Orfaly VE; Kovalenko I; Tolkachjov SN; Ortega-Loayza AG; Nunley JR
Clin Exp Dermatol; 2021 Aug; 46(6):1082-1085. PubMed ID: 33864685
[TBL] [Abstract][Full Text] [Related]
19. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis.
Gilmour E; Stewart DG
Br J Dermatol; 2001 Feb; 144(2):397-400. PubMed ID: 11251582
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum of the scalp treated with cyclosporine A.
Patrone P; Bragadin G; De Francesco V; Frattasio A; Stinco G
Int J Dermatol; 2002 Dec; 41(12):916-8. PubMed ID: 12492988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
